Idiopathic dilated cardiomyopathy
- Catherine E. Cooke,
- Michael D. Greenberg,
- ,
- Kenneth Mishark,
- Masato Odawara,
- Kamejiro Yamashita
- University of Sciences in Philadelphia,
- Georgetown University,
- Tulane University,
- United States Air Force Academy,
- University of Tsukuba,
- University of Texas MD Anderson Cancer Center
Scholary Output:
Contribution to journal
Letter
Research
Peer-reviewOpen access
Abstract
To the Editor: Dec and Fuster (Dec. 8 issue)1 categorized the use of beta-blockers in patients with idiopathic dilated cardiomyopathy as investigational. There is now sufficient evidence to support their use as adjunctive therapy. Numerous clinical trials have evaluated the use of beta-blockers in conjunction with angiotensin-converting—enzyme inhibitors, nitrates, diuretics, and digoxin in patients with idiopathic dilated cardiomyopathy and have found improvements in ejection fraction, cardiac index, and New York Heart Association class and a decreased number of hospital admissions and cardiac transplantations.2—4 However, there have been trials5,6 that did not show such improvements. This is probably because.
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 1384-1386 (3 pages)Journal (Volume, Issue Number)
New England Journal of Medicine (Volume 332, Issue 20)Publication milestones
- Published - 05/18/1995
Publication status
Published - 05/18/1995
ISSN
0028-4793Publication IDs
- Scopus: 0029647395
- PubMed: 7772174
Publication metrics
Metrics
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
7
